Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$167.36 USD
+0.20 (0.12%)
Updated Sep 4, 2024 04:00 PM ET
After-Market: $167.60 +0.24 (0.14%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth F Momentum F VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Top 34% (86 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.24 | 1.98 | 9.99 |
Current Quarter Estimate | 2.19 | 37.53 | 61.00 |
Year Ago Quarter Estimate | 2.66 | 12.41 | 54.84 |
Next Quarter Estimate | 2.33 | 38.15 | 63.00 |
Next Year Estimate | 10.62 | 172.65 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 1.01 | 6.40 | 15.67 |
Next Year | 5.99 | 16.40 | 11.34 |
Last 5 Years | 4.20 | 2.90 | 8.10 |
Next 5 Years | 6.10 | 11.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 15.97 | 22.60 |
Price/Book (MRQ) | 5.63 | 6.38 |
Price/Cash Flow (MRFY) | 12.25 | 12.28 |
Dividend Yield | 2.96% | 2.01% |
Net Profit Margin (TTM) | 46.34% | 18.86% |
Return on Equity (TTM) | 36.60% | 34.56% |
Debt to Equity (MRQ) | 0.44 | 40.19 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.